Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual fluorescence readthrough reporter
Nucleic Acids Research · 08.05.2024 · 52 (8) · 4483-4501
DOI: 10.1093/nar/gkae240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 08.04.2024. Verfasst von Zuyao Ni und 13 weiteren Autor:innen. Beteiligte Einrichtung: Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, ON M5S 3E1, Canada. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Genes, Reporter, mRNA Cleavage and Polyadenylation Factors, RNA Precursors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, CIHR Postdoctoral Fellowship.
Abstract (Originalsprache)
Messenger RNA precursors (pre-mRNA) generally undergo 3′ end processing by cleavage and polyadenylation (CPA), which is specified by a polyadenylation site (PAS) and adjacent RNA sequences and regulated by a large variety of core and auxiliary CPA factors. To date, most of the human CPA factors have been discovered through biochemical and proteomic studies. However, genetic identification of the human CPA factors has been hampered by the lack of a reliable genome-wide screening method. We describe here a dual fluorescence readthrough reporter system with a PAS inserted between two fluorescent reporters. This system enables measurement of the efficiency of 3′ end processing in living cells. Using this system in combination with a human genome-wide CRISPR/Cas9 library, we conducted a screen for CPA factors. The screens identified most components of the known core CPA complexes and other known CPA factors. The screens also identified CCNK/CDK12 as a potential core CPA factor, and RPRD1B as a CPA factor that binds RNA and regulates the release of RNA polymerase II at the 3′ ends of genes. Thus, this dual fluorescence reporter coupled with CRISPR/Cas9 screens reliably identifies bona fide CPA factors and provides a platform for investigating the requirements for CPA in various contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, ON M5S 3E1, Canada.
- Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5A 1A8, Canada.
- Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON Canada.
- Institute for Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON Canada.
ORCID-Profile: Giovanni L Burke, Jason Moffat, Jack F Greenblatt
Förderung
- CIHR
- Canadian Institutes of Health Research
- CIHR Postdoctoral Fellowship
Zitieren
APA
Ni, Z., Ahmed, N., Nabeel-Shah, S., Guo, X., Pu, S., Song, J., Marcon, E., Burke, G. L., Tong, A. H. Y., Chan, K., Ha, K. C. H., Blencowe, B. J., Moffat, J., & Greenblatt, J. F. (2024). Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual fluorescence readthrough reporter. Nucleic Acids Research, 52(8), 4483-4501. https://doi.org/10.1093/nar/gkae240
Vancouver
Ni Z, Ahmed N, Nabeel-Shah S, Guo X, Pu S, Song J, et al. Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual fluorescence readthrough reporter. Nucleic Acids Research. 2024;52(8):4483-4501. doi:10.1093/nar/gkae240
BibTeX
@article{Ni2024,
author = {Ni, Zuyao and Ahmed, Nujhat and Nabeel-Shah, Syed and Guo, Xinghua and Pu, Shuye and Song, Jingwen and Marcon, Edyta and Burke, Giovanni L and Tong, Amy Hin Yan and Chan, Katherine and Ha, Kevin C H and Blencowe, Benjamin J and Moffat, Jason and Greenblatt, Jack F},
title = {Identifying human pre-mRNA cleavage and polyadenylation factors by genome-wide CRISPR screens using a dual fluorescence readthrough reporter},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {8},
pages = {4483--4501},
doi = {10.1093/nar/gkae240}
}
EUVIMED